Study Evaluating GS-5245 in Nonhospitalized Participants With COVID-19
Status:
Not yet recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to test if GS-5245 is safe and effective for the treatment of
COVID-19 in participants who have a standard risk of developing severe illness. The study
will also measure how much GS-5245 gets into the blood and how long it takes for the body to
get rid of it.